Developmental outcomes of different feeding treatments. by Noah H. Rose (703745)

Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP₂ by Shunda Yang (8086265)

“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”

Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP₂ by Shunda Yang (8086265)

“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”

Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP₂ by Shunda Yang (8086265)

“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”

Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP₂ by Shunda Yang (8086265)

“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”

Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP₂ by Shunda Yang (8086265)

“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”

Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP₂ by Shunda Yang (8086265)

“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”

Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP₂ by Shunda Yang (8086265)

“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”

Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP₂ by Shunda Yang (8086265)

“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”

Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP₂ by Shunda Yang (8086265)

“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”

Raw data. by Adrian Bartoszek (20826922)

“…Seizures were induced by adding PTZ to achieve a final concentration of 20 mM. In the PTZ-induced seizure model, the application of CAF in doses over 50 mg/L resulted in a decrease in the average movement. …”

Ca²⁺ supplementation <i>in vitro</i> increases the cytokine production of primary monocytes. by Yusuf Cem Eskiocak (10789281)

Ca²⁺ supplementation <i>in vitro</i> increases the cytokine production of primary human B cells. by Yusuf Cem Eskiocak (10789281)

Stimulation of human lymphoid cells in RPMI^suppl has no negative effect on cell viability. by Yusuf Cem Eskiocak (10789281)

MF induced EGFR interaction. by Xia Wu (203682)

“…C: The DEP FI decrease percentages in EGFR monomer solution with pretreatment of PD of a serial of concentration. …”

Elasticity values for variables for a simulated population of female fishers. by Roger A. Powell (21222116)

Ca²⁺ supplementation <i>in vitro</i> has no impact on the expression of CD69 and the production IL-2, IFNγ, IL-4, and IL-17 by primary human <i>i</i>NKT cells. by Yusuf Cem Eskiocak (10789281)

Exploiting the 2‑Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery by Pasquale Linciano (4426435)

“…In particular, compound <b>4m</b>, a biphenyl-thiadiazole-2,5-diamine with IC₅₀ = 16 μM, was able to potentiate the antitrypanosomal activity of the dihydrofolate reductase inhibitor methotrexate (MTX) with a 4.1-fold decrease of the EC₅₀ value. …”

Exploiting the 2‑Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery by Pasquale Linciano (4426435)

“…In particular, compound <b>4m</b>, a biphenyl-thiadiazole-2,5-diamine with IC₅₀ = 16 μM, was able to potentiate the antitrypanosomal activity of the dihydrofolate reductase inhibitor methotrexate (MTX) with a 4.1-fold decrease of the EC₅₀ value. …”

Exploiting the 2‑Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery by Pasquale Linciano (4426435)

“…In particular, compound <b>4m</b>, a biphenyl-thiadiazole-2,5-diamine with IC₅₀ = 16 μM, was able to potentiate the antitrypanosomal activity of the dihydrofolate reductase inhibitor methotrexate (MTX) with a 4.1-fold decrease of the EC₅₀ value. …”